Results 191 to 200 of about 675,123 (288)

Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story. [PDF]

J Endocrinol Invest
Faggiano A.
europepmc   +1 more source

Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study. [PDF]

Oncologist, 2020
Brighi N, Panzuto F, Modica R, Gelsomino F, Albertelli M, Pusceddu S, Massironi S, Lamberti G, Rinzivillo M, Faggiano A, Spallanzani A, Ferone D, Prinzi N, Rossi RE, Annibale B, Colao AM, Campana D.   +16 more
europepmc   +1 more source

Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.

Journal of Clinical Endocrinology and Metabolism, 2013
R. Pas, R. Feelders, F. Gatto, C. Bruin, A. M. Pereira, P. Koetsveld, D. Sprij-Mooij, A. M. Waaijers, F. Dogan, Stefan Schulz, J. Kros, S. Lamberts, L. Hofland   +12 more
semanticscholar   +1 more source

Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following pancreatic neuroendocrine tumor resection: a case report. [PDF]

Surg Case Rep
Umino R, Nara S, Kobayashi N, Mizui T, Takamoto T, Ban D, Esaki M, Hiraoka N, Shimada K.   +8 more
europepmc   +1 more source

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

Journal of Clinical Endocrinology and Metabolism, 2012
H. Chahal, G. Trivellin, C. Leontiou, Neda Alband, R. Fowkes, Asil Tahir, Susana Igreja, J. Chapple, S. Jordan, A. Lupp, S. Schulz, O. Ansorge, N. Karavitaki, E. Carlsen, J. Wass, Ashley B. Grossman, Ashley B. Grossman, M. Korbonits   +17 more
semanticscholar   +1 more source

Clinical review: Current scientific rationale for the use of somatostatin analogs and mTOR inhibitors in neuroendocrine tumor therapy.

Journal of Clinical Endocrinology and Metabolism, 2012
C. Bousquet, C. Lasfargues, M. Chalabi, Siham Moatassim Billah, C. Susini, D. Vezzosi, P. Caron, S. Pyronnet   +7 more
semanticscholar   +1 more source

Antitumor effects of somatostatin analogs in neuroendocrine tumors.

The Oncologist, 2012
L. Sidéris, P. Dubé, A. Rinke
semanticscholar   +1 more source